
    
      A randomized, open-label, single-dose, four-period, two-way, crossover study to compare the
      pharmacokinetics and safety CKD-828 (Fixed Dose Combination Tablet) to coadministration
      telmisartan and s-amlodipine in health volunteers.
    
  